Avi Dixit

Avi Dixit is an accomplished professional in business development and operations with a strong background in the biotechnology and social media sectors. Currently serving as the Director of Business Development at NJ Bio, Inc. since May 2024, Avi previously held the position of VP of Business Operations at Bionavigen from June 2021 to May 2024. Notably, Avi worked as a Business Development Consultant for NextCure, Inc. in 2023 and was the CEO and Co-founder of Sweeble, a social media app launched in 2023 that achieved 60,000 users within its first nine months. Avi also founded Bubblews.com and served as a Computational Toxicologist during an ORISE Fellowship at the Food & Drug Administration, where a predictive model for drug-drug inhibition was developed and presented at the 2012 Society of Toxicology Convention. Avi's educational background includes a degree from West Virginia University.